Moreover, obesity-related neuroinflammation has been shown to impair serotonin transporter (SERT) expression in the hippocampus, potentially elucidating the diminished responsiveness to SSRIs observed in obese individuals with comorbid depression (54). This evidence concerns the gene SLC6A4 and depressive disorder.